Exercise is known to protect and enhance cognitive function in normal aging through increased blood flow and upregulation of neurotrophic factors in the brain. One recent study suggests that carriers of a known genetic risk factor for Alzheimer's disease (AD), the apolipoprotein E (APOE) E4 allele, may exhibit a more profound benefit of exercise on neurocognitive function relative to non-E4 carriers. Brain imaging studies in cognitively normal, middle-aged E4 carriers have revealed deficits in temporal and parietal cortical function even in the absence of clinical symptoms of dementia. As exercise has been shown to protect these regions in normal aging, and even enhance cortical functioning, the current study employs magnetoencephalograp...
As we age, the body as well as the brain changes in shape and function. Some of these changes are co...
Physical and cognitive exercise may prevent or delay dementia in later life but the neural mechanism...
Cortical atrophy is a biomarker of Alzheimer’s disease (AD) that correlates with clinical symptoms. ...
Leisure-time physical activity (PA) and exercise training are known to help maintain cognitive funct...
Performance on the Sternberg working memory task, and MEG cortical response on a variation of the St...
Leisure time physical activity (PA) and exercise training help to improve and maintain cognitive fun...
Physical Activity (PA) and Cognitive Activity (CA) are generally considered protective for Alzheimer...
Current treatment in late-life cognitive impairment and dementia is still limited, and there is no c...
Western countries are experiencing aging populations and increased longevity; thus, the incidence of...
This is not the final published version.Exercise and cardiorespiratory (CR) fitness may moderate age...
Evidence suggests that physical activity (PA) is associated with the maintenance of cognitive functi...
Despite a growing number of functional MRI studies reporting exercise-induced changes during cogniti...
The apolipoproteinE epsilon4 (APOE-?4) allele is associated with cognitive decline in old age and is...
Despite strong evidence from animal models of Alzheimer's disease (AD) supporting aerobic exercise a...
Abstract Exercise likely has numerous benefits for brain and cognition. However, those benefits and ...
As we age, the body as well as the brain changes in shape and function. Some of these changes are co...
Physical and cognitive exercise may prevent or delay dementia in later life but the neural mechanism...
Cortical atrophy is a biomarker of Alzheimer’s disease (AD) that correlates with clinical symptoms. ...
Leisure-time physical activity (PA) and exercise training are known to help maintain cognitive funct...
Performance on the Sternberg working memory task, and MEG cortical response on a variation of the St...
Leisure time physical activity (PA) and exercise training help to improve and maintain cognitive fun...
Physical Activity (PA) and Cognitive Activity (CA) are generally considered protective for Alzheimer...
Current treatment in late-life cognitive impairment and dementia is still limited, and there is no c...
Western countries are experiencing aging populations and increased longevity; thus, the incidence of...
This is not the final published version.Exercise and cardiorespiratory (CR) fitness may moderate age...
Evidence suggests that physical activity (PA) is associated with the maintenance of cognitive functi...
Despite a growing number of functional MRI studies reporting exercise-induced changes during cogniti...
The apolipoproteinE epsilon4 (APOE-?4) allele is associated with cognitive decline in old age and is...
Despite strong evidence from animal models of Alzheimer's disease (AD) supporting aerobic exercise a...
Abstract Exercise likely has numerous benefits for brain and cognition. However, those benefits and ...
As we age, the body as well as the brain changes in shape and function. Some of these changes are co...
Physical and cognitive exercise may prevent or delay dementia in later life but the neural mechanism...
Cortical atrophy is a biomarker of Alzheimer’s disease (AD) that correlates with clinical symptoms. ...